T cell and Antibody Responses of Subjects Participating in GEN, a Phase 1 2a Clinical Trial To Evaluate the Safety and Immunogenicity of a Novel Therapeutic Vaccine Against HSV-2 - HSV - Document - PDFSEARCH.IO

First Page	Meta Content
	T cell and Antibody Responses of Subjects Participating in GEN, a Phase 1/2a Clinical Trial To Evaluate the Safety and Immunogenicity of a Novel Therapeutic Vaccine Against HSV-2 Add to Reading List Document Date: 2014-07-23 09:37:39 Open Document File Size: 1.003,79 KB Share Result on Facebook City Kobe / / Company Chiron / IgG / / Country Japan / / MedicalCondition infection / infections / Moderate-to-severe infections / / PublishedMedium Baseline / / Technology antibodies / / SocialTag Microbiology Animal virology Herpesviruses Herpesviridae Herpes simplex Virus Interferon Vaccine Sexually transmitted diseases and infections Biology

T cell and Antibody Responses of Subjects Participating in GEN, a Phase 1/2a Clinical Trial To Evaluate the Safety and Immunogenicity of a Novel Therapeutic Vaccine Against HSV-2Add to Reading List